HomeCompareIQAIF vs XYLD

IQAIF vs XYLD: Dividend Comparison 2026

IQAIF yields 10000.00% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IQAIF wins by $55137509079256512.00M in total portfolio value
10 years
IQAIF
IQAIF
● Live price
10000.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55137509079256512.00M
Annual income
$54,073,795,673,722,890,000,000.00
Full IQAIF calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — IQAIF vs XYLD

📍 IQAIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIQAIFXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IQAIF + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IQAIF pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IQAIF
Annual income on $10K today (after 15% tax)
$850,000.00/yr
After 10yr DRIP, annual income (after tax)
$45,962,726,322,664,450,000,000.00/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, IQAIF beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IQAIF + XYLD for your $10,000?

IQAIF: 50%XYLD: 50%
100% XYLD50/50100% IQAIF
Portfolio after 10yr
$27568754539628256.00M
Annual income
$27,036,897,836,861,443,000,000.00/yr
Blended yield
98.07%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IQAIF buys
0
XYLD buys
0
No recent congressional trades found for IQAIF or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIQAIFXYLD
Forward yield10000.00%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$55137509079256512.00M$25.3K
Annual income after 10y$54,073,795,673,722,890,000,000.00$3,219.02
Total dividends collected$55066727460582336.00M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: IQAIF vs XYLD ($10,000, DRIP)

YearIQAIF PortfolioIQAIF Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$1,010,700$1,000,000.00$10,818$1,098.39+$999.9KIQAIF
2$95,539,393$94,457,943.93$11,738$1,222.51+$95.53MIQAIF
3$8,447,007,736$8,344,780,585.66$12,774$1,364.64+$8446.99MIQAIF
4$698,565,746,383$689,527,448,105.17$13,944$1,527.86+$698565.73MIQAIF
5$54,040,711,670,213$53,293,246,321,583.74$15,270$1,715.87+$54040711.65MIQAIF
6$3,910,851,616,519,516$3,853,028,055,032,387.00$16,775$1,933.09+$3910851616.50MIQAIF
7$264,781,167,546,477,440$260,596,556,316,801,570.00$18,490$2,184.87+$264781167546.46MIQAIF
8$16,772,556,223,821,672,000$16,489,240,374,546,942,000.00$20,450$2,477.63+$16772556223821.65MIQAIF
9$994,124,678,068,810,000,000$976,178,042,909,320,800,000.00$22,697$2,819.19+$994124678068810.00MIQAIF
10$55,137,509,079,256,515,000,000$54,073,795,673,722,890,000,000.00$25,280$3,219.02+$55137509079256512.00MIQAIF

IQAIF vs XYLD: Complete Analysis 2026

IQAIFStock

IQ-AI Limited focuses on advancing healthcare by developing and commercializing state-of-the-art medical software solutions and services. In March 2018, IQ-AI Ltd acquired Imaging Biometrics, LLC (IB), a Wisconsin USA-based medical imaging software company. In addition to providing regulatory consulting services, IB supplies medical technology solutions and has a strong neuroimaging product portfolio. IB's analytical solutions enable clinicians to better diagnose and treat disease with greater confidence. IB is the second acquisition made by IQ-AI in the medical imaging space after acquiring Stone Checker Software Ltd in 2017.

Full IQAIF Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this IQAIF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IQAIF vs SCHDIQAIF vs JEPIIQAIF vs OIQAIF vs KOIQAIF vs MAINIQAIF vs QYLDIQAIF vs JEPQIQAIF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.